Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease

BACKGROUND AND OBJECTIVES: Disease-specific treatment options for autosomal dominant polycystic kidney disease are limited. Clinical intervention early in life is likely to have the greatest effect. In a 3-year randomized double-blind placebo-controlled phase 3 clinical trial, the authors recently s...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin J Am Soc Nephrol
Main Authors: Klawitter, Jelena, McFann, Kim, Pennington, Alexander T., Wang, Wei, Klawitter, Jost, Christians, Uwe, Schrier, Robert W., Gitomer, Berenice, Cadnapaphornchai, Melissa A.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2015
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559520/
https://ncbi.nlm.nih.gov/pubmed/26224879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11331114
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki